A Process For Preparation Of Azoxystrobin

Nacl Industries Limited
Application Awaiting Examination App No 202447015552 Chemical

Patent information

IP India · live record
Application number
202447015552
Filing date
02 March 2024
Status
Application Awaiting Examination
Publication number
12/2024
Publication type
INA
Invention field
Chemical

Abstract

A process for preparation of azoxystrobin is provided. The process includes two different routes for preparing the azoxystrobin using catalyst selected from a group consisting of 4-methylmorpholine, 1,4-dimethylpiperazine, 2,2,6,6-tetramethylpiperidine, 1-methylpiperidine, and 2,2'-oxybis (N, N- dimethylethan-1-amine). The catalysts used in the process are cost-effective and have low boiling point, thus are easily recyclable. The process provided by the present invention provides higher yields and purity of the azoxystrobin than the conventional methods.

Applicants

1
India
NACL INDUSTRIES LIMITED Plot No 12-A, C Block, Lakshmi Towers, Nagarjuna Hills, Punjagutta, Hyderabad 500082

Inventors

7
India
BHOOPAL, MekaFlat No 304, Block-A, Vertex Pleasant, Brindavan Colony, Nizampet Road, Hyderabad 500072
India
VENKATREDDY, S.Flat no 402, Meenkshi developers, beside Shardha Laxminarasimha Swamy Temple, New Gayatri Nagar, Jillalguda, Hyderabad 500097
India
SATYANARAYANA GOUD, TirupathiBhogaram, Street-Kosgi, City-Mahabubnagar, State -Telangana, India Mahabubnagar 509339
India
CHANDRA SEKHAR, AndeH No 5-2, PRAGADA KOTAIAH NAGAR, TENALI-522201, GUNTUR (dist), ANDHRA PRADESH, INDIA TENALI 522201
India
RAJA, MalisettiH No 1-18, PAKALAGUDEM - 507303, SATTUPALLY (Mandal), KHAMMAM (Dist), TELANGANA, INDIA PAKALAGUDEM 507303
India
SHASHIDHAR KUMAR, AkubathiniFLAT 401, SREESAINIVAS APT, STREET NO 6, KARTHIKEYA NAGAR, NACHARAM - 500076, UPPAL (MANDAL), MEDCHAL-MALKAJGIRI (Dist), HYDERABAD, TELANGANA, INDIA HYDERABAD 500076
India
SINGH, Sunil KumarNACL Industries Ltd., Plot No 12-A, C Block, Lakshmi Towers, Nagarjuna Hills, Punjagutta, Hyderabad - 500082, TELANGANA, INDIA HYDERABAD 500082

Claims

10
1 A process for the preparation of Azoxystrobin of formula-1, comprising: (a) reacting (E)-3-(methoxy methylene) benzofuran-2(3H)-one of formula-2 with sodium methoxide and 4,6-dichloropyrimidine in presence of a catalyst to obtain the mixture of azoxystrobin intermediates of formula-4, and formula-5; (b) reacting the mixture of azoxystrobin intermediates of formula-4, and formula-5 with methanesulfonic acid or p-toluenesulfonic acid to obtain methyl (E)-2-{2-[6-chloropyrimidin-4- yloxy]phenyl}-3-methoxyacrylate of formula-5; and (c) coupling of 2-cyanophenol with methyl (E)-2-{2-[6-chloropyrimidin-4-yloxy]phenyl}-3- methoxyacrylate of formula-5 to obtain the azoxystrobin of formula-1.
2 The process as claimed in claim 1, the catalyst used in stage (a) is selected from a group consisting of 4-methylmorpholine, 1,4-dimethylpiperazine, 2,2,6,6-tetramethylpiperidine, 1- methylpiperidine, and 2,2'-oxybis (N, N-dimethylethan-1-amine) and the reaction medium used in stage (a) includes inorganic base selected from potassium carbonate or sodium carbonate and the solvent used in stage (a) selected from toluene or ethylene dichloride.
3 The process as claimed in claim 1, the mixture of the azoxystrobin intermediates comprise methyl 2-[2-(6-chloropyrimidin-4-yloxy) phenyl]-3,3-dimethoxypropionate of formula-4 and methyl (E)-2-{2-[6-chloropyrimidin-4-yloxy] phenyl}-3-methoxyacrylate of formula-5.
4 The process as claimed in claim 1, reaction medium used in stage (b) includes acetic anhydride or propionic anhydride and the solvent used in stage (b) selected from toluene or ethylene dichloride.
5 The process as claimed in claim 1, stage (c) is carried out in presence of the catalyst bis[2-(N,Ndimethylamino)ethyl] ether and the reaction medium used in stage (c) includes potassium carbonate and dimethyl formamide.
6 A process for the preparation of Azoxystrobin of formula-1, comprising: (a) reacting (E)-3-(methoxy methylene) benzofuran-2(3H)-one of formula-2 with sodium methoxide and 4,6-dichloropyrimidine in presence of a catalyst to obtain the mixture of azoxystrobin intermediates of formula-4, and formula-5; (b) coupling of 2-cyanophenol with the mixture of azoxystrobin intermediates of formula-4, and formula-5 to obtain the mixture of variants of azoxystrobin of formula-7, and formula-1; and (c) reacting the mixture of variants of azoxystrobin of formula-7, and formula-1 with methanesulfonic acid or p-toluenesulfonic acid to isolate the pure azoxystrobin of formula-1.
7 The process as claimed in claim 6, the catalyst used in stage (a) is selected from a group consisting of 4-methylmorpholine, 1,4-dimethylpiperazine, 2,2,6,6-tetramethylpiperidine, 1- methylpiperidine, and 2,2'-oxybis (N, N-dimethylethan-1-amine) and the reaction medium used in stage (a) includes an inorganic base selected from potassium carbonate or sodium carbonate and the solvent used in stage (a) selected from toluene or ethylene dichloride.
8 The process as claimed in claim 6, the mixture of azoxystrobin intermediates comprise methyl 2- [2-(6-chloropyrimidin-4-yloxy) phenyl]-3,3-dimethoxypropionate of formula-4 and methyl (E)- 2-{2-[6-chloropyrimidin-4-yloxy] phenyl}-3-methoxyacrylate formula-5.
9 The process as claimed in claim 6, the catalyst used in stage (b) is bis[2-(N,Ndimethylamino)ethyl] ether and the reaction medium used in stage (b) includes potassium carbonate and dimethyl formamide.
10 The process as claimed in claim 6, the reaction medium used in stage (c) includes acetic anhydride or propionic anhydride and the solvent used in stage (c) selected from toluene or ethylene dichloride.

Specification

Show full textCollapse

We Claim: 1. A process for the preparation of Azoxystrobin of formula-1, comprising: (a) reacting (E)-3-(methoxy methylene) benzofuran-2(3H)-one of formula-2 with sodium methoxide and 4,6-dichloropyrimidine in presence of a catalyst to obtain the mixture of azoxystrobin intermediates of formula-4, and formula-5; (b) reacting the mixture of azoxystrobin intermediates of formula-4, and formula-5 with methanesulfonic acid or p-toluenesulfonic acid to obtain methyl (E)-2-{2-[6-chloropyrimidin-4-yloxy]phenyl}-3-methoxyacrylate of formula-5; and (c) coupling of 2-cyanophenol with methyl (E)-2-{2-[6-chloropyrimidin-4-yloxy]phenyl}-3-methoxyacrylate of formula-5 to obtain the azoxystrobin of formula-1.

2. The process as claimed in claim 1, the catalyst used in stage (a) is selected from a group consisting of 4-methylmorpholine, 1,4-dimethylpiperazine, 2,2,6,6-tetramethylpiperidine, 1-methylpiperidine, and 2,2'-oxybis (N, N-dimethylethan-1-amine) and the reaction medium used in stage (a) includes inorganic base selected from potassium carbonate or sodium carbonate and the solvent used in stage (a) selected from toluene or ethylene dichloride. 3. The process as claimed in claim 1, the mixture of the azoxystrobin intermediates comprise methyl 2-[2-(6-chloropyrimidin-4-yloxy) phenyl]-3,3-dimethoxypropionate of formula-4 and methyl (E)-2-{2-[6-chloropyrimidin-4-yloxy] phenyl}-3-methoxyacrylate of formula-5.

4. The process as claimed in claim 1, reaction medium used in stage (b) includes acetic anhydride or propionic anhydride and the solvent used in stage (b) selected from toluene or ethylene dichloride. 5. The process as claimed in claim 1, stage (c) is carried out in presence of the catalyst bis[2-(N,Ndimethylamino)ethyl] ether and the reaction medium used in stage (c) includes potassium carbonate and dimethyl formamide. 6. A process for the preparation of Azoxystrobin of formula-1, comprising: (a) reacting (E)-3-(methoxy methylene) benzofuran-2(3H)-one of formula-2 with sodium methoxide and 4,6-dichloropyrimidine in presence of a catalyst to obtain the mixture of azoxystrobin intermediates of formula-4, and formula-5; (b) coupling of 2-cyanophenol with the mixture of azoxystrobin intermediates of formula-4, and formula-5 to obtain the mixture of variants of azoxystrobin of formula-7, and formula-1; and (c) reacting the mixture of variants of azoxystrobin of formula-7, and formula-1 with methanesulfonic acid or p-toluenesulfonic acid to isolate the pure azoxystrobin of formula-1.

7. The process as claimed in claim 6, the catalyst used in stage (a) is selected from a group consisting of 4-methylmorpholine, 1,4-dimethylpiperazine, 2,2,6,6-tetramethylpiperidine, 1-methylpiperidine, and 2,2'-oxybis (N, N-dimethylethan-1-amine) and the reaction medium used in stage (a) includes an inorganic base selected from potassium carbonate or sodium carbonate and the solvent used in stage (a) selected from toluene or ethylene dichloride.

8. The process as claimed in claim 6, the mixture of azoxystrobin intermediates comprise methyl 2- [2-(6-chloropyrimidin-4-yloxy) phenyl]-3,3-dimethoxypropionate of formula-4 and methyl (E)- 2-{2-[6-chloropyrimidin-4-yloxy] phenyl}-3-methoxyacrylate formula-5. 9. The process as claimed in claim 6, the catalyst used in stage (b) is bis[2-(N,Ndimethylamino)ethyl] ether and the reaction medium used in stage (b) includes potassium carbonate and dimethyl formamide. 10. The process as claimed in claim 6, the reaction medium used in stage (c) includes acetic anhydride or propionic anhydride and the solvent used in stage (c) selected from toluene or ethylene dichloride.

Documents

Sign in to open
Application documents
1 202447015552-STATEMENT OF UNDERTAKING (FORM 3) [02-03-2024(online)].pdf 02 Mar 2024
2 202447015552-REQUEST FOR EXAMINATION (FORM-18) [02-03-2024(online)].pdf 02 Mar 2024
3 202447015552-FORM 1 [02-03-2024(online)].pdf 02 Mar 2024
4 202447015552-FIGURE OF ABSTRACT [02-03-2024(online)].pdf 02 Mar 2024
5 202447015552-DRAWINGS [02-03-2024(online)].pdf 02 Mar 2024
6 202447015552-DECLARATION OF INVENTORSHIP (FORM 5) [02-03-2024(online)].pdf 02 Mar 2024
7 202447015552-COMPLETE SPECIFICATION [02-03-2024(online)].pdf 02 Mar 2024